Index

Q2 TD Cowen/AFS Freight Index: Parcel surcharge changes wring out additional revenue, LTL and truckload rates hold steady

Retrieved on: 
Tuesday, April 9, 2024
DAS, AFS, LTL, Transport, GRI, ZIP, FedEx, Yoy, Index, Quarter, UPS, Cargo

ATLANTA, April 9, 2024 /PRNewswire/ -- AFS Logistics, an industry-leading third-party logistics (3PL) provider, and TD Cowen announce the second quarter (Q2) 2024 release of the TD Cowen/AFS Freight Index, a snapshot with predictive pricing for truckload, less-than-truckload (LTL) and parcel transportation markets. The latest release of the index expects LTL and truckload rates to remain steady, consistent with trends established since Q2 of last year. In parcel, the index shows the effect of fuel surcharge increases and other accessorial changes to drive net rate growth in Q1 and Q2 2024, despite limited overall demand.

Key Points: 
  • The latest release of the index expects LTL and truckload rates to remain steady, consistent with trends established since Q2 of last year.
  • In parcel, the index shows the effect of fuel surcharge increases and other accessorial changes to drive net rate growth in Q1 and Q2 2024, despite limited overall demand.
  • "While truckload and LTL markets are largely a continuation of established trends, parcel carriers have unleashed a wave of key pricing changes to raise revenue," says Tom Nightingale, CEO of AFS.
  • The ground parcel fuel surcharge is based on the U.S. on-highway diesel fuel index , and express is based on the U.S. Gulf Coast kerosene-type jet fuel .

Chris Meredith Joins J.P. Morgan Asset Management Solutions as CIO of Tax Smart Strategies

Retrieved on: 
Tuesday, April 9, 2024
CIO, Spinal muscular atrophies, Research, Growth, James O'Shaughnessy (investor), Index, JPMorgan Chase, ETF, Security (finance)

NEW YORK, April 9, 2024 /PRNewswire/ -- J.P. Morgan Asset Management today announced that Chris Meredith is joining as Chief Investment Officer (CIO) - Tax-Smart Strategies.

Key Points: 
  • NEW YORK, April 9, 2024 /PRNewswire/ -- J.P. Morgan Asset Management today announced that Chris Meredith is joining as Chief Investment Officer (CIO) - Tax-Smart Strategies.
  • Mr. Meredith joins J.P. Morgan Asset Management at a time where advisors and their clients are prioritizing seamless, digital-first experiences.
  • As CIO of Tax-Smart Strategies, Mr. Meredith will also partner closely to develop new products and capabilities with 55ip, J.P. Morgan Asset Management's tax-smart technology platform.
  • "I'm incredibly excited to join J.P. Morgan Asset Management Solutions as CIO of Tax-Smart Strategies," added Mr. Meredith.

The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation

Retrieved on: 
Monday, April 8, 2024
Freedom, Atrial fibrillation, Risk, Patient, Stroke, PFA, Medtronic, Femoral vein, Pulse, Heart failure, Ventricular fibrillation, MPH, Index, Heart, Safety, AAD, Annual general meeting, Cardiac tamponade, Pulmonary vein stenosis

DUBLIN and BERLIN, April 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive clinical trial safety and efficacy results for Sphere-360™, an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy, for treatment of patients with paroxysmal atrial fibrillation (AFib). Interim findings from the first-in-human Sphere-360 study were presented as a late-breaking clinical trial at the European Heart Rhythm Association (EHRA) 2024 Annual Meeting.

Key Points: 
  • Interim findings from the first-in-human Sphere-360 study were presented as a late-breaking clinical trial at the European Heart Rhythm Association (EHRA) 2024 Annual Meeting.
  • The Sphere-360 catheter was developed with the goal to simplify the atrial fibrillation procedure while enhancing efficiency and providing high durability of lesions.
  • Furthermore, the catheter is fully integrated with the Affera™ Mapping and Ablation System for complete visualization inside the heart and electroanatomical mapping, making it a true all-in-one single-shot catheter for mapping, ablation, and validation.
  • "These results are very encouraging as they show the Sphere-360 catheter has the potential to be an important part of next generation AFib care."

KARORA RESOURCES ANNOUNCES MERGER TRANSACTION WITH WESTGOLD RESOURCES

Retrieved on: 
Monday, April 8, 2024
CIBC, Agreement, GDX, Westgold Resources, Sale, G&A, AWST, OTCQX, Corporate spin-off, CBCA, Policy, Toronto Stock Exchange, KRR, Combined, Big Bell, Arrangement, Index, Safety, VWAP, Multilateral, Bluebird, ASX, TSX, Stikeman Elliott, Canada Business Corporations Act, Transaction, Good, Mining, Shareholder Meeting, Growth, Gold, FIRB, Security (finance)

TORONTO, April 7, 2024 /CNW/ - Karora Resources Inc. (TSX: KRR) (OTCQX: KRRGF) ("Karora") and Westgold Resources Limited (ASX: WGX) (OTCQX: WGXRF) ("Westgold") have agreed to combine in a merger pursuant to which Westgold will acquire 100% of the issued and outstanding common shares of Karora ("Karora Shares") by way of a statutory plan of arrangement under the Canada Business Corporations Act ("CBCA") ("Transaction").

Key Points: 
  • TORONTO, April 7, 2024 /CNW/ - Karora Resources Inc. (TSX: KRR) (OTCQX: KRRGF) ("Karora") and Westgold Resources Limited (ASX: WGX) (OTCQX: WGXRF) ("Westgold") have agreed to combine in a merger pursuant to which Westgold will acquire 100% of the issued and outstanding common shares of Karora ("Karora Shares") by way of a statutory plan of arrangement under the Canada Business Corporations Act ("CBCA") ("Transaction").
  • Karora shareholders will receive 2.5241 Westgold fully paid ordinary shares ("Westgold Shares"), A$0.68 (C$0.611) in cash and 0.30 of a share in a new company to be spun-out from Karora ("SpinCo") for each Karora Share held at the closing of the Transaction ("Offer Consideration").
  • Upon completion of the Transaction, existing Westgold and Karora shareholders will own approximately 50.1% and 49.9% of Enlarged Westgold, respectively.
  • The Transaction has been unanimously approved by the boards of directors of Westgold and Karora, and Karora's board of directors unanimously recommends that Karora shareholders vote in favour of the Transaction.

Manheim Index: Wholesale Used Vehicle Values Lower than Expected in March, as Prices Cool in Final Week of Q1

Retrieved on: 
Friday, April 5, 2024
Smoke, Health, SUV, MMR, EVS, SAAR, Transport, Cox Enterprises, Index, Mileage, Government, Propane

Spring bounce in vehicle sales ended early this year, with both wholesale and retail sales slowing in the final week of Q1.

Key Points: 
  • Spring bounce in vehicle sales ended early this year, with both wholesale and retail sales slowing in the final week of Q1.
  • ATLANTA, April 5, 2024 /PRNewswire/ -- Wholesale used-vehicle prices (on a mix, mileage, and seasonally adjusted basis) were down in March compared to February.
  • The Manheim Used Vehicle Value Index (MUVVI) fell to 203.1, a decline of 14.7% from a year ago.
  • In March, Manheim Market Report (MMR) values saw weekly increases slightly below long-term averages for the last several weeks.

Kinetica Delivers Real-Time Vector Similarity Search

Retrieved on: 
Wednesday, March 20, 2024
Cloud, Synthetic media, ANN, OLAP, Gen, Algorithm, GPU, SQL, General partnership, RAG, SAN, Motion, Anomaly, LLM, Architecture, RAFT, Acceleration, Index, Language, NVIDIA, ANSI, Generative, Weather, Cryptocurrency

SAN JOSE, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Kinetica, the real-time GPU-accelerated database for analytics and generative AI, today unveiled at NVIDIA GTC the industry’s only real-time vector similarity search engine that can ingest vector embeddings 5X faster than the previous market leader, based on the popular VectorDBBench benchmark. Under the hood Kinetica uses NVIDIA RAPIDS RAFT to harness the power of the GPU for vector similarity search. With Kinetica’s best-in-class combined data and query latency for vector embedding pipelines, large language models (LLM) can immediately augment their results with new information via embeddings as soon as they are generated, without delays at scale.

Key Points: 
  • Under the hood Kinetica uses NVIDIA RAPIDS RAFT to harness the power of the GPU for vector similarity search.
  • High performance vector similarity search at speed and scale - Kinetica vectorization enables vector similarity search (exact nearest neighbor) at speed and scale even without an index.
  • Hybrid vector search combines similarity search with time-series, spatial, graph & OLAP through SQL - Build more powerful Generative AI applications by combining vector similarity search with filters, joins, aggregations, etc.
  • “By taking advantage of NVIDIA RAPIDS vector search, Kinetica can offer higher throughput, lower latency and faster index builds for Gen AI applications.”
    Kinetica’s vector similarity search is now available in Kinetica 7.2 for users of Kinetica Cloud Dedicated, Developer Edition, and Kinetica Enterprise.

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

Retrieved on: 
Tuesday, March 19, 2024
Diary, Patient, IND, Adolescence, Pediatrics, Therapy, FAAP, Rett syndrome, Research, Central nervous system, Risk, Webcast, CNS, Ageing, CHU, Safety, AAV, Mutation, Development, MECP2, Disease, Associate, Sleep, Șaeș, Dysrhythmia, FRCP, MTD, Movement, IDMC, VG, Hyperventilation, Principal, Administration, Index, Seizure, CTA, Female, MHRA, Phenotype, ID, Frasier, Pharmaceutical industry

Notably, she has vastly increased interest in social communication and activities at week 35 compared to earlier post-treatment assessments.

Key Points: 
  • Notably, she has vastly increased interest in social communication and activities at week 35 compared to earlier post-treatment assessments.
  • Dr. Schultz is a board-certified, licensed pediatric neurologist experienced in treating patients with Rett syndrome and leading gene therapy clinical trials.
  • She brings more than 17 years of clinical experience and will lead the Company’s clinical development, clinical operations, medical affairs and safety activities.
  • ET to review its financial and operating results and to provide corporate and clinical updates.

Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates

Retrieved on: 
Tuesday, March 19, 2024
HER2, Acute leukemia, Exercise, Index, Exchange, Colorectal cancer, MMR, Memorial, Headache, Patient, Research, Diarrhea, Brain, CML, KOL, Aes, Sale, Cancer, Security (finance), IND, MBA, Prospectus, MBC, Nausea, Therapy, CRC, PIPE, Pharmacokinetics, MTD, Food, Pharmaceutical industry

BOULDER, Colo., March 19, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today announced that it has entered into a securities purchase agreement for a private investment in public equity (PIPE) financing that is expected to result in gross proceeds of approximately $90 million, before deducting offering expenses. The financing includes participation from new and existing investors, including Commodore Capital, Fairmount, Venrock Healthcare Capital Partners, a biotech investor, a large mutual fund, Rock Springs Capital, Logos Capital, Woodline Partners LP and Acuta Capital Partners.

Key Points: 
  • “The additional funding further strengthens our balance sheet and enables us to achieve critical, longer-term clinical milestones as we advance our parallel lead programs, ELVN-001 and ELVN-002.
  • Enliven anticipates the gross proceeds from the private placement to be approximately $90 million, before deducting offering expenses.
  • The PIPE financing is expected to close on or about March 21, 2024, subject to satisfaction of customary closing conditions.
  • Any offering of the securities under the resale registration statement will only be made by means of a prospectus.

Voltron Data Advances Theseus, Making It the First Petabyte Scale Query Engine for Large Scale Data Processing

Retrieved on: 
Monday, March 18, 2024
Organization, Government, GPU, Memory, SAN, Parquetry, AI, TPC, Graphics processing unit, Index, NVIDIA, HPE

“Voltron Data is playing an important role in bridging analytics and AI infrastructure usage in the Era of AI.

Key Points: 
  • “Voltron Data is playing an important role in bridging analytics and AI infrastructure usage in the Era of AI.
  • “Theseus enables enterprises to use GPUs to quickly analyze log data, machine data and large amounts of tabular data generated on the fly – this is because GPUs are great at processing data, especially for data moving too fast to thoroughly index due to its sheer computational power.
  • Theseus points to data where it lies and uses hardware accelerator's sheer computational power to analyze massive data as quickly as possible.
  • HPE is the first partner to embed Theseus as its accelerated data processing engine as part of HPE Ezmeral Unified Analytics Software .

DeFi Technologies’ Wholly-Owned Subsidiary Valour Inc., Bitcoin Suisse AG, and STOXX Launch the 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP

Retrieved on: 
Monday, March 18, 2024
Bitcoin, Crypto, ETP, NEO, Exchange-traded product, Partnership, Classification, Digital, GCT, Decentralized finance, OTC, Index, Cryptocurrency, Culture

Launch of 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP: DeFi Technologies Inc. announces a collaborative product from Valour Inc., Bitcoin Suisse AG, and STOXX, offering a diversified investment in top blue-chip digital assets through a new Exchange Traded Product (ETP).

Key Points: 
  • Launch of 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP: DeFi Technologies Inc. announces a collaborative product from Valour Inc., Bitcoin Suisse AG, and STOXX, offering a diversified investment in top blue-chip digital assets through a new Exchange Traded Product (ETP).
  • Innovative Methodology and Partnerships: The ETP, tracking the STOXX Digital Asset Blue Chip X Index, is based on a rule-based passive index methodology, leveraging Bitcoin Suisse's Global Crypto Taxonomy for asset classification.
  • We are proud to collaborate with well established and trusted partners in the global financial markets for the launch of this innovative product.“
    The 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP is uniquely structured to track the performance of the STOXX Digital Asset Blue Chip X Index.
  • This ETP is the result of a synergistic collaboration between Valour, Bitcoin Suisse, and STOXX, each bringing unique strengths to the table.